Concepedia

John Reader

JR

30

Publications

1.5K

Citations

21

H-Index

1982

Active since

Affiliations

Institute of Cancer Research(Current)

Imperial College London

Cancer Research UK

University of Worcester

University College London

John Reader is an author at Institute of Cancer Research specializing in organic chemistry, chemistry, and medicine.

Top concepts

Publications per year

1982–2021

30

Publications

30

Complex synthetic chemical libraries indexed with molecular tags.

Michael Ohlmeyer, R. N. Swanson, Lawrence W. Dillard et al. · Proceedings of the National Academy of Sciences · 1993 · 444 citations · Full text

, , +12

Gilbert Simondon: Being and Technology

John Reader · International Journal of Engineering Social Justice and Peace · 2013 · 120 citations · Full text

, , +21

The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106

Michael I. Walton, Paul D. Eve, Angela Hayes et al. · Molecular Cancer Therapeutics · 2010 · 101 citations · Full text

, , +18

CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

Mike I. Walton, Paul D. Eve, Angela Hayes et al. · Clinical Cancer Research · 2012 · 92 citations · Full text

The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma

Mike I. Walton, Paul D. Eve, Angela Hayes et al. · Oncotarget · 2015 · 68 citations · Full text

, , +19

Rows per page

1–5 of 30